Page 84 - 《中国药房》2025年7期
P. 84
PI3K激活剂740 Y-P,结果显示,Met对PI3K/AKT/PDGF 作用机制[J]. 中西医结合心脑血管病杂志,2024,22(9):
信号通路的抑制作用可被740 Y-P逆转。 1604-1609.
综上所述,Met可改善NASH大鼠肝损伤,减轻炎症 [13] 彭晓娟,钟绿,吴楚添,等. 青钱柳多糖和青钱柳黄酮对
反应和肝纤维化,其作用机制可能与抑制 PI3K/AKT/ 非酒精性脂肪性肝病合并 2 型糖尿病模型大鼠血液代
PDGF信号通路活性有关。 谢指标及肝脏病变的影响[J]. 中国病理生理杂志,2021,
37(10):1838-1847.
参考文献
[14] BHARATH L P,NIKOLAJCZYK B S. The intersection
[ 1 ] LIN Z B,YANG P J,HU Y F,et al. Ring finger protein 13
of metformin and inflammation[J]. Am J Physiol Cell
protects against nonalcoholic steatohepatitis by targeting
Physiol,2021,320(5):C873-C879.
STING-relayed signaling pathways[J]. Nat Commun,
[15] RUAN G Y,WU F Q,SHI D B,et al. Metformin:update
2023,14(1):6635.
on mechanisms of action on liver diseases[J]. Front Nutr,
[ 2 ] XU X H,POULSEN K L,WU L J,et al. Targeted thera‐
2023,10:1327814.
peutics and novel signaling pathways in non-alcohol-
[16] GUO M D,ZHU C H,FU R Z,et al. Ginsenoside Rk3
associated fatty liver/steatohepatitis (NAFL/NASH)[J].
regulates nonalcoholic steatohepatitis by modulation of in‐
Signal Transduct Target Ther,2022,7(1):287.
testinal flora and the PI3K/AKT signaling pathway in
[ 3 ] FORETZ M,GUIGAS B,VIOLLET B. Metformin:up‐
C57BL/6 mice[J]. J Agric Food Chem,2023,71(24):
date on mechanisms of action and repurposing potential
9370-9380.
[J]. Nat Rev Endocrinol,2023,19(8):460-476.
[17] SONG J,QIU H R,DU P,et al. Polyphenols extracted
[ 4 ] 李瑞芳,卜淑蕊. 二甲双胍对高脂饮食诱导的非酒精性
from Shanxi-aged vinegar exert hypolipidemic effects on
脂肪性肝病大鼠肠道菌群的影响[J]. 中华消化杂志,
OA-induced HepG2 cells via the PPARα-LXRα-ABCA1
2020,40(12):861-867.
pathway[J]. J Food Biochem,2022,46(2):e14029.
[ 5 ] SONG H,ZHANG X J,ZHAI R Q,et al. Metformin at‐
[18] 郭威,李三强,宋晓改,等 . L-谷氨酰胺对急性酒精肝损
tenuated sepsis-associated liver injury and inflammatory
伤小鼠的保护作用机制研究[J]. 中国临床药理学杂志,
response in aged mice[J]. Bioengineered,2022,13(2): 2020,36(13):1812-1814.
4598-4609.
[19] DUAN Y M,PAN X F,LUO J Y,et al. Association of
[ 6 ] 吕春卉,李大炜,王小洁,等. 二甲双胍联合辛伐他汀治
inflammatory cytokines with non-alcoholic fatty liver
疗非酒精性脂肪性肝病合并 2 型糖尿病患者疗效研究 disease[J]. Front Immunol,2022,13:880298.
[J]. 实用肝脏病杂志,2022,25(1):50-53. [20] FENG Y Y,WANG Z J,PANG H. Role of metformin in
[ 7 ] YU Y J,ZHOU S Z,WANG Y,et al. Leonurine alleviates inflammation[J]. Mol Biol Rep,2023,50(1):789-798.
acetaminophen-induced acute liver injury by regulating [21] LI J D,WANG T Q,LIU P P,et al. Hesperetin ameliorates
the PI3K/AKT signaling pathway in mice[J]. Int Immuno‐ hepatic oxidative stress and inflammation via the PI3K/
pharmacol,2023,120:110375. AKT-Nrf2-ARE pathway in oleic acid-induced HepG2
[ 8 ] XU X Y,GENG Y,XU H X,et al. Antrodia camphorata- cells and a rat model of high-fat diet-induced NAFLD[J].
derived antrodin C inhibits liver fibrosis by blocking TGF- Food Funct,2021,12(9):3898-3918.
beta and PDGF signaling pathways[J]. Front Mol Biosci, [22] WALLACE S J,TACKE F,SCHWABE R F,et al. Under‐
2022,9:835508. standing the cellular interactome of non-alcoholic fatty
[ 9 ] YE Q,LIU Y,ZHANG G J,et al. Deficiency of gluconeo‐ liver disease[J]. JHEP Rep,2022,4(8):100524.
genic enzyme PCK1 promotes metabolic-associated fatty [23] WANG Y F,WANG P Y,YU Y B,et al. Hepatocyte Nin‐
liver disease through PI3K/AKT/PDGF axis activation in jurin2 promotes hepatic stellate cell activation and liver fi‐
male mice[J]. Nat Commun,2023,14(1):1402. brosis through the IGF1R/EGR1/PDGF-BB signaling
[10] EMAN E,HEMAT E,HANAA H,et al. Effects of berberine pathway[J]. Metabolism,2023,140:155380.
on high-fat/high-sucrose-induced nonalcoholic steatohepa‐ [24] WANG S,CHEN B H,DU R L,et al. An herbal formula‐
titis in experimental rats[J]. Tanta Med J,2019,47(2):80. tion “Shugan xiaozhi decoction” ameliorates methionine/
[11] 岳亚光,檀薇薇,王文川,等 . 二甲双胍经 Nrf2-Gpx4 通 choline deficiency-induced nonalcoholic steatohepatitis
路抑制铁死亡并减轻非酒精性脂肪性肝病大鼠的肝损 through regulating inflammation and apoptosis-related
伤[J]. 中国病理生理杂志,2021,37(10):1848-1857. pathways[J]. J Ethnopharmacol,2024,329:118127.
[12] 李彩艳,王东枝,张冰,等 . 基于瘦素介导的 PI3K/AKT (收稿日期:2024-10-12 修回日期:2025-02-08)
通路探讨二甲双胍对脑卒中相关性肺炎大鼠肺损伤的 (编辑:唐晓莲)
· 842 · China Pharmacy 2025 Vol. 36 No. 7 中国药房 2025年第36卷第7期